December 15, 2011

Determining the Prevalence and Progression of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

  • Study Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
  • Start Date: 2/2001
  • End Date: Ongoing
  • Design: Longitudinal study
  • Age range (years): 18 and older
  • Type of PH: Hem - APAH
  • Study Duration for Individual Patient (weeks): 0.14
  • Listing on

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Terms of Use    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2017 Pulmonary Hypertension Association. All Rights Reserved.

BBB Accredited Charity BEST in AmericaCharity Navigator

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.